Skip to main content

Table 1 Laboratory data on admission

From: Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case

Complete blood count    HBV and HCV serology
WBC 6,700/μL ChE 292 IU/L HBsAg (-)
RBC 480 ×104/μL LDH 261 IU/L HBsAb (-)
Hb 14.1 g/dL T-Chol 245 mg/dL HBeAg (-)
Hct 43.0 % TP 7.4 g/dL HBeAb (-)
Plt 24.9 ×104/μL Alb 4.3 g/dL HBcAb (-)
   Na 139 mEq/L HCVAb (-)
Coagulation tests K 4.8 mEq/L   
PT-INR 0.99 Cl 101 mEq/L Tumor markers
APTT 32.3 sec Ca 9.4 mg/dL AFP 46,300 ng/mL
Blood chemistry UA 7.9 mg/dL PIVKA-II 28,555mAU/mL
AST 104 IU/L UN 17.6 mg/dL   
ALT 68 IU/L Cr 1.25 mg/dL Dye clearance test
ALP 353 IU/L CRP 0.28 mg/dL ICG-R 15 14.5 %
γGTP 175 IU/L HbA1c 7.5 %   
T.Bil 0.8 mg/dL eGFR 43.7 mL/min/1.73 m2   
  1. AFP alpha-fetoprotein, Alb albumin, ALT alanine aminotransferase, ALP alkaline phosphatase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, ChE cholinesterase, CRP C-reactive protein, eGFR estimated glomerular filtration rate, γGTP gamma glutamyl transpeptidase, HBV hepatitis B virus, Hb hemoglobin, HbA1c hemoglobin A1c, Hct hematocrit, HCV hepatitis C virus, ICG-R 15 indocyanine green dye retention rate at 15 min, LDH lactate dehydrogenase, Plt platelets, PT-INR prothrombin time-international normalized ratio, RBC red blood cells, T.Bil total bilirubin, T.Chol total cholesterol, PIVKA-II protein induced by vitamin K absence or antagonist, TP total protein, UA uric acid, UN urea nitrogen, WBC white blood cells